Finance

Beta
Lists
PALI:NASDAQ
Palisade Bio Inc
$1.97
-5.74%
(-0.12) 1D
$2.05
+4.06% (+0.080)
Pre-market
Closed: Jul 1, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PALI...
Open
$2.10
High
$2.17
Low
$1.96
Mkt. cap
341.95M
Avg. vol.
3.86M
Volume
103.00
52-wk high
$2.86
52-wk low
$0.53
EPS
-$1.17
Beta
1.52
Shares outstanding
173.58M
No. of employees
14
Open
$2.10
High
$2.17
Low
$1.96
Mkt. cap
341.95M
Avg. vol.
3.86M
Volume
103.00
52-wk high
$2.86
52-wk low
$0.53
EPS
-$1.17
Beta
1.52
Shares outstanding
173.58M
No. of employees
14
News stories
From sources across the web
About Palisade Bio Inc
CEO-
Employees14
Founded2005
HeadquartersCarlsbad, California, United States
SectorBiotechnology
Websitepalisadebio.com
Analyst ratings
Based on 6 analysts giving stock ratings to PALI in the past 3 months
Strong buy
Buy
6
Hold
0
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for PALI in the last 3 months.
Highest
Current $1.97
$25.00 (+1,169.04%)
Average
$9.83 (+398.98%)
Lowest
$5.00 (+153.81%)
Analyst
Recommendation
Action
Price target
Projected
Date
Naz Rahman
Maxim Group
Buy
Reiterated
$8.00
+306.1%
06/29/2026
Mitchell Kapoor
H.C. Wainwright
Buy
Reiterated
$7.00
+255.3%
06/30/2026
William Wood
B. Riley Securities
Buy
Reiterated
$7.00
+255.3%
06/02/2026
Yasmeen Rahimi
Piper Sandler
Buy
Reiterated
$25.00
+1,169%
04/13/2026
Andy Chen
Wolfe Research
Buy
Initiated
$7.00
+255.3%
04/08/2026
Alex Thompson CFA
Stifel Nicolaus
Buy
Maintained
$5.00
+153.8%
04/04/2026
Kaveri Pohlman
Clear Street
Buy
Maintained
$12.00
+509.1%
03/31/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1.68M
1.39M
6.17M
6.40M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.17M
1.53M
3.81M
4.35M
Operating expense
2.84M
2.92M
9.98M
10.75M
Total operating expenses
2.84M
2.92M
9.98M
10.75M
Operating income
-2.84M
-2.92M
-9.98M
-10.75M
Other non operating income
61.00K
59.00K
1.08M
1.15M
EBT including unusual items
-2.78M
-2.87M
-8.90M
-9.60M
EBT excluding unusual items
-2.78M
-2.87M
-8.90M
-9.60M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-2.78M
-2.87M
-8.90M
-9.60M
Net profit margin
-
-
-
-
Earnings per share
-0.58
-0.38
-
-0.05
Interest and investment income
-
-
-
-
Interest expense
-2.00K
-5.00K
-2.00K
-1.00K
Net interest expenses
-2.00K
-5.00K
-2.00K
-1.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-2.84M
-2.92M
-9.98M
-10.75M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create portfolio
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer